Calcium channel blockers activate the interleukin-6 gene via the transcription factors NF-IL6 and NF-kappaB in primary human vascular smooth muscle cells.
Ikeda
U
U
Ito
T
T
Shimada
K
K
D022762:CCAAT-Enhancer-Binding Proteins; D002121:Calcium Channel Blockers / Q000494:pharmacology*; D004268:DNA-Binding Proteins / Q000502:physiology*; D006801:Humans; D015850:Interleukin-6 / Q000235:genetics* / Q000378:metabolism; D009131:Muscle, Smooth, Vascular / Q000187:drug effects* / Q000378:metabolism; D016328:NF-kappa B / Q000502:physiology*; D009687:Nuclear Proteins / Q000502:physiology*; D014157:Transcription Factors / Q000502:physiology*
D022762:CCAAT-Enhancer-Binding Proteins; D002121:Calcium Channel Blockers; D004268:DNA-Binding Proteins; D015850:Interleukin-6; D016328:NF-kappa B; D009687:Nuclear Proteins; D014157:Transcription Factors